Desotamide B [V2I;l3i]

General Information


DRACP ID  DRACP03699

Peptide Name   Desotamide B [V2I;l3i]

Sequence  NIiLWG

Sequence Length  6

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  Mix



Physicochemical Information


Formula  C29H41N7O6

Absent amino acids  ACDEFHKMPQRSTVY

Common amino acids  GILNW

Mass  67306

Pl  6.11

Basic residues  0

Acidic residues  0

Hydrophobic residues  3

Net charge  0

Boman Index  647

Hydrophobicity  58.33

Aliphatic Index  130

Half Life 
  /

Extinction Coefficient cystines  5500

Absorbance 280nm  1100

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 29125222

Title  Total Synthesis and Antibacterial Study of Cyclohexapeptides Desotamide B, Wollamide B and Their Analogs

Doi Not available

Year  2018

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  11352

DRACP is developed by Dr.Zheng's team.